text
stringlengths
9
72.5k
Most of the important choices we make in life are not dictated by Scripture. So, what do we do?
Men, consider the damage that an adulterous affair can have and pray for God to steer you down the right path.
If you haven’t done it already, take time out to set your family agenda for 2013. Be sure, of course, that God is included in your goals.
Former Charisma editor J. Lee Grady shares a word he received for 2013. He pleads with Christians not to give up on this nation. God can orchestrate a miraculous turnaround in the United States.
Like physical hunger and thirst, Christians experience spiritual hunger and thirst every day. Our meals, however, have already been bought.
New Year’s resolutions are sometimes difficult to keep, but these are worth following through on.
If she isn’t able to vocalize her opinion on crucial matters, you may lose your wife in more ways than one.
Being a Christian in the workplace puts you on the frontline of reaching people.
The message may be harsh, but many of us can skip the silly rhetoric that we see on some church signs these days.
Having a good overview of the story and structure of God’s Word will bolster your Bible confidence—so you don’t have to walk into church feeling queasy.
Respected pastor Joel Hunter shares five simple prayers that always get results! Check these out.
A man must replace his negative passion with a positive one versus just resisting the darkness.
It’s not hard to imagine a spiritual battle raging in the cosmos over the souls of men.
The term “platform” used to mean a horizontal wooden structure on top of which rosettes are given to particularly attractive farm animals. In these politically tumultuous times, however, it has taken on a much more contentious meaning, (except perhaps at the Puck Fair, where I understand platforms have always been contentious). A platform is now broadly understood to mean a space, either physical or digital, where one individual’s voice may be heard over others. Who gets to have a platform has become one of the most significant questions of our time, after the “Who did Jay-Z cheat on Beyoncé with?” one of course.
The New Yorker magazine came under pressure this month over its decision to invite the former Trump adviser Steve Bannon onto its platform. The magazine, a major media brand and intellectual home for liberal thinkers, had planned a one-on-one public interview of Bannon by its editor David Remnick. The event was billed as part of its annual festival programme. I’m free that weekend, by the way, Mr Remnick, if your programme needs an opinion on the minutiae of product design.
The announcement created an online backlash from the considerable number of people who find Bannon’s views on immigration and other topics morally repugnant. Indeed, many feel his tenure at the Breitbart website, where he oversaw such headlines as “Hoist it high and proud: The Confederate flag proclaims a glorious heritage” and “Would you rather your child had feminism or cancer?”, was the beginning of the breakdown of civility in American discourse.
To them, the New Yorker event would provide an opportunity for Bannon to popularise white supremacist views. Subscriptions to the magazine were cancelled and many of the festival’s other high-profile guests, including comedians Jim Carrey, Judd Apatow and John Mulaney, took the stand of cancelling their attendance. The pressure was on the festival to revoke the invitation. It worked. Twenty-four hours later Bannon was out.
And then came the backlash to the backlash. Another sizeable group of liberal thinkers objected to the de-platforming of Bannon. They agreed with Remnick, who defended the invitation saying that to interview Bannon or anyone was in no way to endorse their views. The only way to probe unpalatable views, they said, is to allow them on the platform where someone of an opposing viewpoint can apply pressure to them. To cancel the event, they believe, is a missed opportunity to force the architect of the Trump presidency to defend his handiwork in public.
And so a huge schism now divides liberal politics. To “platform” or to “no platform”? One side certain that allowing white supremacist views on any platform presents too real a threat to minorities, who suffer hate crime at increasing rates. The other certain that such a risk must be taken if the US is to be rescued from the grip of right-wing populism.
It’s not just in America where this debate is playing out. In Portugal, Irish Web Summit impresario Paddy Cosgrave rescinded his invitation to the leader of France’s National Rally party, Marine Le Pen, partly “out of respect for our host country”. In the UK, Bannon is still invited to an event at the Economist magazine’s Open Future festival later this month despite cancellations from other speakers. Holding the interview at a respectful distance from the scene of the speaker’s perceived crime seems to be solving the problem for now.
Getting an accurate read on how big an influence discussions have on public behaviour is difficult. However, the schism itself reveals something about the way interview, debate and those who practice it, the liberal media, are perceived. Platformers, many journalists themselves, have an unshakeable faith in their power of intellect and reason to defeat bad ideas. “Guys, calm down. We got this. We have the measure of Bannon’s kind,” they seem to say. No-platformers doubt them. “White supremacy needs no debate. It’s simply wrong. And it is not the people who profit from this festival who will pay the price if you fail,” is the reply.
The outcome of recent events, however, seem to support the no-platformers. Interviews with far-right extremists (who never seem to turn down any platform) have not resulted in anything near the definitive victory one might expect. Indeed Hillary Clinton – who had more than sufficient knowledge, expertise and experience to trounce the floundering charlatan Trump – still lost the election. Perhaps people are questioning if those on our TVs are really as smart as they claim to be.
And thus I offer the backlash to the backlash to the backlash. What if the question we ask is not the correct one? Instead of asking if white supremacists should ever be offered a platform, perhaps we should ask how the liberal media can strengthen the one it has? This is what journalists and, in particular, broadcasters must do if they want to be trusted with the precarious job of interviewing leaders of the far right.
In the meanwhile, any journalist still harbouring ideas that they can beat Bannon with data and statistics needs to dig deeper. He and his ilk will make them look foolish. It’s possible the entertainers who pulled out of the New Yorker festival know something about playing to the whole room and not just those they shared a dorm with.
Remnick’s choice to debate Bannon in a festival setting when the political stakes are so high was dangerously naive. I’ve never been to a festival where everyone didn’t end up in the bar together at the end of the night. But then again I’ve never been to the Puck Fair. Perhaps that’s an assumption I need to question.
Newly promoted Alaves stunned Spanish champions Barcelona by winning 2-1 at the Camp Nou as boss Luis Enrique paid a heavy price for starting Lionel Messi and Luis Suarez on the bench.
Barca now trail Real Madrid by three points at the top of the table after Cristiano Ronaldo took just five minutes to score on his return from a two-month injury layoff in a 5-2 rout of Osasuna at the Bernabeu.
Enrique made seven changes from their last outing — a 1-0 win at Athletic Bilbao two weeks ago — with Messi recovering from a groin problem and Suarez rested following his exertions in World Cup qualifying with Uruguay.
“It wasn’t a good day from the start, we weren’t precise enough,” said Enrique.
His wholesale changes backfired as Barca failed to unlock Alaves’s mass ranks of defence before the break and went behind when Deyverson turned Kiko Femenia’s cross past Jasper Cillessen on his Barca debut.
Neymar was the only one of Barca’s star “MSN” front three to start on his first appearance of the season after leading Brazil to Olympic gold and should have levelled moments later when he failed to hit the target with a free header inside the area.
The Brazilian provided the assist as Jeremy Mathieu headed home Barca’s equaliser from a corner a minute after the break and the French defender somehow blasted wide with the goal gaping moments later.
Messi was summoned on the hour mark, but there was another shock to come for the hosts when Ibai Gomez took advantage of some awful Barca defending to put Alaves back in front.
Andres Iniesta and Suarez were also called upon as the “MSN” were reunited for the first time in four months, but even they couldn’t break the Alaves resistance as the Basques held out for their first La Liga win in a decade.
“We couldn’t find the speed or precision we needed at the right moments,” lamented Iniesta.
Ronaldo was making his first appearance since limping off in tears during the Euro 2016 final, but was handed the perfect return on a plate by Gareth Bale as the Welshman squared for him to tap into an unguarded net.
“The truth is I started a bit warily, which is normal after a serious injury, but I feel good, without pain and getting back to full fitness,” said Ronaldo.
Despite failing to hit top gear Real comfortably matched a club record of 15 straight La Liga wins as Danilo’s low drive and a towering header from Sergio Ramos extended the lead before half-time at the Bernabeu.
Osasuna goalkeeper Nauzet Perez meekly turned Pepe’s header into his own net for Real’s fourth before Luka Modric’s fiercely struck shot from outside the box made it 5-0.
However, Real’s defensive deficiencies were exposed in the second half as Oriol Riera and David Garcia cut Osasuna’s deficit, whilst Roberto Torres saw a penalty saved by Kiko Casilla.
Antoine Griezmann handed Atletico Madrid a much-needed first win of the season in a 4-0 victory at Celta Vigo.
Koke met Griezmann’s fine cross eight minutes into the second half in Vigo to give the visitors the lead before Euro 2016’s top scorer Griezmann headed home his first two goals of the season in the final 20 minutes.
Angel Correa added a fourth two minutes from time.
“We needed a game like this,” Griezmann told BeIN Sports Spain.
Las Palmas’s 100 percent start to the campaign was ended in cruel fashion in a 2-1 defeat at Sevilla. Tana’s fine first-half strike for the Canary Islanders was cancelled out by a dubious Pablo Sarabia penalty a minute from time before Carlos Fernandez bundled home a stoppage-time winner.
Villarreal secured their first victory of the season, winning 2-0 at Malaga thanks to first-half goals from Jaume Costa and Nicola Sansone.
Radioactive crystals left behind by ancient bacteria tell us about a long-ago supernova nearby.
About 2.6 million years ago, a gigantic star exploded 300 light years away from earth. The explosion was close enough that if we’d been here, we might well have seen its flash in the sky. As our solar system passed through the cloud of stardust left behind some of its radioactive iron-60 particles fell through the atmosphere, settling at the bottom of the ocean where it amazingly still remains thanks to some hungry ancient bacteria. And the timing of the blast is particularly intriguing because it aligns with a major oceanic extinction event on earth. Toxic stardust could explain it.
Iron-60 isn’t native to our world. It comes only from supernovae, and it was found in our Pacific oceanic crust in 2004.
Initial attempts to figure out when the stardust arrived were unsuccessful because its iron-60 particles were in sediment that builds up at the stately rate of a millimeter every million years. That makes any kind of precise measurement and analysis difficult.
The explosion wasn’t properly dated until recently in a study from the Proceedings of the National Academy of Sciences (PNAS). A more measurable, faster-growing kind of sediment — it goes from 10 to 20 meters every million years — allowed scientists to nail down the timing. (The study also revealed that it took 800 million years for the solar system to pass through the stardust cloud.) But these scientists aren’t the heroes of our story.
The reason the iron-60 hasn’t oxidized into and broken down is that its nano-scale particles were ingested by a particular type of bacteria — our heroes — that fed on them. These bacteria are unusual in that they grow dozens of itty-bitty bar magnets, actually crystals of oxygen and iron. When the bacteria die, what’s left behind are the crystals, and that’s where scientists found the telltale signs our exploding star.
So a long-ago lunch of the most tiny iron-hungry bacteria turns out to have led us to something utterly huge: a massive nearby star explosion that fairly rocked our world nearly three million years ago.
There is no fundamental difference between Democrats and Republicans. The terms left and right are meaningless. Most of Americas modern wars were started not by conservatives, but by liberal Democrats.
And This Is Your Resistance?
All I can say is thank goodness for the voices that speak out like Jimmy. Please watch.
Please people watch this. The last thing we need is to be into another darn war! This isn't the only source on this I've been posting on here or reading about on other sites.
As he weighed whether to support President Barack Obama's nuclear deal with Iran, Representative Donald Norcross was showered with the sort of attention rarely shown to junior members of the U.S. Congress.
Israeli Ambassador Ron Dermer's message to House Democrats is simple: don't worry about voting against the Iran deal, because no matter what, the U.S. will do what we tell it to do.
Netanyahu needs to speak because Israel cannot expect indefinite support from the US if it acts like a fretful and obedient client to a cavalier American patron. The margin of IsraelâEUR(TM)s security is measured by the respect of friends and enemies alike.
US lawmakers flock to Israel to receive instructions on how to conduct US foreign policyâEUR"a sign of obedience and accountability to their constituency.
America's wars are very expensive. Bush and Obama have doubled the national debt, and the American people have no benefits from it. No riches, no bread and circuses flow to Americans from Washington's wars. So what is it all about?
Arundhati Roy: "The People Who Created the Crisis Will Not Be the Ones That Come Up With a Solution"
Barack Obama standing in the Arab world plumbed new depths as protesters in the West Bank furiously denounced his vehement denunciation of their Palestinian Statehood bid.
Let's make one thing crystal clear, no member of the US military contributes in any way whatsoever to protecting the freedoms of the American people.
Come and see this amazing 2BR/2BA with its own private balcony in a secluded neighborhood off of South College. Updates include new carpeting, freshly painted throughout with a mounted television to enjoy. Close to Girard Park, the Oil Center, Lafayette General Hospital and UL. There is also a pool on the premises to cool off during the hot summer months. Call today!
Do you know the answers to these basic questions about your Medicare coverage? Find out here.
If you don't already rely on Medicare for your healthcare needs, you will eventually. Knowing the basics of how the program works is essential to make sure you'll have the coverage you'll need.
Roughly 55 million Americans are on Medicare, and about 10,000 new enrollees sign up every day. Yet despite how important Medicare is, many people don't know the facts about it. Below, we'll give some of the most-common questions, and some simple answers to them.
1. Do I qualify for Medicare?
You can qualify for Medicare if you or your spouse has earned the required number of credits while working at a job at which you paid Medicare payroll taxes. It takes 40 credits to get full coverage without having to pay a premium for Medicare Part A hospital insurance, and it typically takes someone 10 years of work in order to earn 40 credits.
Those who have fewer than 40 credits can still get Medicare coverage, but they have to pay for their hospital insurance coverage with monthly premiums. A reduced rate is available for those with 30 to 39 credits compared to those with fewer than 30 credits.
Note that, even if you never worked in a job in which you paid payroll taxes to Medicare, you can still get coverage if you're a U.S. citizen, or a legal resident for at least five years. Again, the key difference is that you'll pay up to $411 per month for your hospital coverage.
2. When can I sign up for Medicare?
Most people first become eligible for Medicare when they turn age 65. The initial enrollment period for Medicare begins three months before your 65th birthday, and extends for three months after you reach 65.
In addition, some people can sign up for Medicare before age 65. If you have certain types of conditions or a disability, then eligibility follows different rules. Disabled people get Part A hospital coverage and Part B medical coverage automatically after receiving Social Security disability benefits for 24 months. Sufferers of ALS, also known as Lou Gehrig's disease, get coverage immediately once disability benefits begin. Coverage for those who have end-stage renal disease get coverage effective on the fourth month of dialysis treatments.
If you are still working, you don't have to sign up for Medicare immediately on turning 65, but many people do anyway. If you have qualifying coverage at work, then Medicare may not be necessary, and you'll be eligible for a special enrollment period when your group coverage at work ends. However, some smaller employers might require you to sign up for Medicare in order to reduce their own health plan's expenses.
3. What choices do I have with Medicare?
Medicare comes with two main choices. If you go with traditional Medicare, then you'll usually sign up for Part A hospital coverage and Part B medical coverage, with prescription drug coverage under Part D being more of an optional benefit. Alternatively, you can go with Medicare Advantage, sometimes known as Medicare Part C, in which a private insurer provides the same benefits that the federal government provides directly for traditional Medicare recipients.
Medicare Advantage plans can come with or without prescription drug coverage, and the options you have for more-extensive coverage are generally more prevalent than you get through traditional Medicare on its own. However, there can be additional costs with Medicare Advantage plans, and so it's important to be sure that the coverage you get matches up well with your healthcare needs.
4. Can I change my Medicare coverage?
Every year, Medicare participants get a chance to change their coverage. The annual open enrollment period runs every year from Oct. 15 to Dec. 7, and during that period, you can do a number of things. If you're in traditional Medicare, you can switch to a Medicare Advantage plan, and if you're in a Medicare Advantage plan, you can switch back to traditional Medicare.
Those who are in Medicare Advantage plans can switch between different plans, and you can change your mind about whether you want Part D prescription-drug coverage included under Medicare Advantage or not. You can also switch drug plans, join a new drug plan, or drop your drug plan entirely.
In addition, there's a special Medicare Advantage disenrollment period from Jan. 1 to Feb. 14. During that period, you can move from a Medicare Advantage plan back to original Medicare only.
5. Do I need other coverage besides Medicare?
Medicare doesn't cover everything. For example, there are 20% copayments for most medical services under traditional Medicare, and deductibles and copays for hospital services can be even higher. Because of this, many Medicare participants get Medigap policies to cover what traditional Medicare doesn't.
Medicare Advantage plans usually cover some of the most-common gaps in traditional Medicare, and so most people don't need supplemental coverage above and beyond what their Medicare Advantage plan provides. It's therefore useful to compare the cost of Medicare Advantage with the total cost of traditional Medicare plus any Medigap policy that you end up buying.
Most retirees rely on Medicare, so it's crucial to know the ins and outs of how the program works. By knowing the answers to these simple questions, you'll have a better sense than most about what you can expect from Medicare when you retire.
WASHINGTON, April 11, 2019 /PRNewswire/ -- DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis' market-leading platform, bringing together the most relevant information to support drug discovery, research and development.
Established in 2005, DrugPatentWatch has served large and small biopharmaceutical interests in more than 65 countries. The DrugPatentWatch platform provides rapid access to actionable business intelligence, helping biopharmaceutical stakeholders make better decisions.
"Working with Adis allows us to distribute our information in a context that will help biotechnology and pharmaceutical companies make better decisions and improve the quality of their portfolio management decisions. Payers can also improve their budgeting, and investors can improve their forecasting of future revenue events," says Dr. Yali Friedman, Chief Executive of DrugPatentWatch. "The team at Adis was a pleasure to work with. Their enthusiasm and focus on improving client outcomes was evident throughout the integration. It is also important to work with a partner that shares our commitment to providing current, actionable, and reliable content. The AdisInsight platform is unparalleled and we are proud to be working with them to deliver an even more valuable service to their customers."
Jeff Southwood, Product Development Director for AdisInsight, says: "Having worked very closely with customers in this space for many years, we know what makes their day-to-day work challenging. One of the major struggles our users face is that they have to rely very heavily on patent attorneys or IP specialists to assess patent protection because of the expertise required to find patents in patent-specific databases and to understand and interpret these complex documents. This can be a time-consuming and costly process. Our goal in developing AdisInsight Patents was to make drug-centric patent information accessible to any user by using familiar search terms and at-a-glance summaries."
The integration of DrugPatentWatch's global patent intelligence into the AdisInsight platform helps users make better decisions with accurate, interlinked narratives about drug development. The combination of patent and market entry information with AdisInsight's strong base will help drug companies and other biopharmaceutical stakeholders improve their decision-making processes and identify new commercial opportunities.
DrugPatentWatch is provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 DrugPatentWatch has served hundreds of large and small companies in more than 65 countries. DrugPatentWatch founder and Chief Executive Yali Friedman, Ph.D. was named one of the "100 most influential people in biotechnology" by Scientific American. Visit https://www.DrugPatentWatch.com and contact (202)780-9367 / 212191@email4pr.com.
Marketing CTAM Summit general session here Monday morning.
even in four to six years.
analog services -- operating within a 10 million HDTV-home universe.
Mark Cuban, chairman and president of HDNet.
to MSOs for $5.50 wholesale.
a monthly price of between $9.95 and $16.